1. Academic Validation
  2. Peroxisome-driven ether-linked phospholipids biosynthesis is essential for ferroptosis

Peroxisome-driven ether-linked phospholipids biosynthesis is essential for ferroptosis

  • Cell Death Differ. 2021 Aug;28(8):2536-2551. doi: 10.1038/s41418-021-00769-0.
Weiwei Cui 1 Dong Liu 1 Wei Gu 2 Bo Chu 3
Affiliations

Affiliations

  • 1 Department of Cell Biology, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China.
  • 2 Institute for Cancer Genetics, and Department of Pathology and Cell Biology, and Herbert Irving Comprehensive Cancer Center, College of Physicians & Surgeons, Columbia University, New York, NY, USA. wg8@cumc.columbia.edu.
  • 3 Department of Cell Biology, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China. chubo123@sdu.edu.cn.
Abstract

It is well established that Ferroptosis is primarily induced by peroxidation of long-chain poly-unsaturated fatty acid (PUFA) through nonenzymatic oxidation by free radicals or enzymatic stimulation of Lipoxygenase. Although there is emerging evidence that long-chain saturated fatty acid (SFA) might be implicated in Ferroptosis, it remains unclear whether and how SFA participates in the process of Ferroptosis. Using endogenous metabolites and genome-wide CRISPR screening, we have identified FAR1 as a critical factor for SFA-mediated Ferroptosis. FAR1 catalyzes the reduction of C16 or C18 saturated fatty acid to fatty alcohol, which is required for the synthesis of alkyl-ether lipids and plasmalogens. Inactivation of FAR1 diminishes SFA-dependent Ferroptosis. Furthermore, FAR1-mediated Ferroptosis is dependent on peroxisome-driven ether phospholipid biosynthesis. Strikingly, TMEM189, a newly identified gene which introduces vinyl-ether double bond into alkyl-ether lipids to generate plasmalogens abrogates FAR1-alkyl-ether lipids axis induced Ferroptosis. Our study reveals a new FAR1-ether lipids-TMEM189 axis dependent Ferroptosis pathway and suggests TMEM189 as a promising druggable target for Anticancer therapy.

Figures
Products